Literature DB >> 21412897

Using alternative statistical formats for presenting risks and risk reductions.

Elie A Akl1, Andrew D Oxman, Jeph Herrin, Gunn E Vist, Irene Terrenato, Francesca Sperati, Cecilia Costiniuk, Diana Blank, Holger Schünemann.   

Abstract

BACKGROUND: The success of evidence-based practice depends on the clear and effective communication of statistical information.
OBJECTIVES: To evaluate the effects of using alternative statistical presentations of the same risks and risk reductions on understanding, perception, persuasiveness and behaviour of health professionals, policy makers, and consumers. SEARCH STRATEGY: We searched Ovid MEDLINE (1966 to October 2007), EMBASE (1980 to October 2007), PsycLIT (1887 to October 2007), and the Cochrane Central Register of Controlled Trials (The Cochrane Library, 2007, Issue 3). We reviewed the reference lists of relevant articles, and contacted experts in the field. SELECTION CRITERIA: We included randomized and non-randomized controlled parallel and cross-over studies. We focused on four comparisons: a comparison of statistical presentations of a risk (eg frequencies versus probabilities) and three comparisons of statistical presentation of risk reduction: relative risk reduction (RRR) versus absolute risk reduction (ARR), RRR versus number needed to treat (NNT), and ARR versus NNT. DATA COLLECTION AND ANALYSIS: Two authors independently selected studies for inclusion, extracted data, and assessed risk of bias. We contacted investigators to obtain missing information. We graded the quality of evidence for each outcome using the GRADE approach. We standardized the outcome effects using adjusted standardized mean difference (SMD). MAIN
RESULTS: We included 35 studies reporting 83 comparisons. None of the studies involved policy makers. Participants (health professionals and consumers) understood natural frequencies better than probabilities (SMD 0.69 (95% confidence interval (CI) 0.45 to 0.93)). Compared with ARR, RRR had little or no difference in understanding (SMD 0.02 (95% CI -0.39 to 0.43)) but was perceived to be larger (SMD 0.41 (95% CI 0.03 to 0.79)) and more persuasive (SMD 0.66 (95% CI 0.51 to 0.81)). Compared with NNT, RRR was better understood (SMD 0.73 (95% CI 0.43 to 1.04)), was perceived to be larger (SMD 1.15 (95% CI 0.80 to 1.50)) and was more persuasive (SMD 0.65 (95% CI 0.51 to 0.80)). Compared with NNT, ARR was better understood (SMD 0.42 (95% CI 0.12 to 0.71)), was perceived to be larger (SMD 0.79 (95% CI 0.43 to 1.15)).There was little or no difference for persuasiveness (SMD 0.05 (95% CI -0.04 to 0.15)). The sensitivity analyses including only high quality comparisons showed consistent results for persuasiveness for all three comparisons. Overall there were no differences between health professionals and consumers. The overall quality of evidence was rated down to moderate because of the use of surrogate outcomes and/or heterogeneity. None of the comparisons assessed behaviourbehaviour. AUTHORS'
CONCLUSIONS: Natural frequencies are probably better understood than probabilities. Relative risk reduction (RRR), compared with absolute risk reduction (ARR) and number needed to treat (NNT), may be perceived to be larger and is more likely to be persuasive. However, it is uncertain whether presenting RRR is likely to help people make decisions most consistent with their own values and, in fact, it could lead to misinterpretation. More research is needed to further explore this question.

Entities:  

Mesh:

Year:  2011        PMID: 21412897      PMCID: PMC6464912          DOI: 10.1002/14651858.CD006776.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  69 in total

1.  Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates.

Authors:  Aisha T Langford; Ken Resnicow; J Scott Roberts; Brian J Zikmund-Fisher
Journal:  J Genet Couns       Date:  2012-01-21       Impact factor: 2.537

2.  Do clinicians understand the size of treatment effects? A randomized survey across 8 countries.

Authors:  Bradley C Johnston; Pablo Alonso-Coello; Jan O Friedrich; Reem A Mustafa; Kari A O Tikkinen; Ignacio Neumann; Per O Vandvik; Elie A Akl; Bruno R da Costa; Neill K Adhikari; Gemma Mas Dalmau; Elise Kosunen; Jukka Mustonen; Mark W Crawford; Lehana Thabane; Gordon H Guyatt
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

3.  The cycle of bias in health research: a framework and toolbox for critical appraisal training.

Authors:  Donna H Odierna; Susan R Forsyth; Jenny White; Lisa A Bero
Journal:  Account Res       Date:  2013       Impact factor: 2.622

4.  Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Authors:  Mark H Eckman; Pablo Alonso-Coello; Gordon H Guyatt; Shanil Ebrahim; Kari A O Tikkinen; Luciane Cruz Lopes; Ignacio Neumann; Sarah D McDonald; Yuqing Zhang; Qi Zhou; Elie A Akl; Ann Flem Jacobsen; Amparo Santamaría; Joyce Maria Annichino-Bizzacchi; Wael Bitar; Per Morten Sandset; Shannon M Bates
Journal:  Thromb Res       Date:  2015-05-22       Impact factor: 3.944

Review 5.  Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review.

Authors:  Tanner J Caverly; Rodney A Hayward; Elyse Reamer; Brian J Zikmund-Fisher; Daniel Connochie; Michele Heisler; Angela Fagerlin
Journal:  J Natl Cancer Inst       Date:  2016-02-24       Impact factor: 13.506

6.  Assessment of Lung Cancer Screening Program Websites.

Authors:  Stephen D Clark; Daniel S Reuland; Chineme Enyioha; Daniel E Jonas
Journal:  JAMA Intern Med       Date:  2020-06-01       Impact factor: 21.873

Review 7.  Prescribers' Knowledge and Skills for Interpreting Research Results: A Systematic Review.

Authors:  Leila Kahwati; Dennis Carmody; Nancy Berkman; Helen W Sullivan; Kathryn J Aikin; Jessica DeFrank
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

8.  Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners.

Authors:  Donna H Odierna; Jenny White; Susan Forsyth; Lisa A Bero
Journal:  Health Expect       Date:  2012-12-16       Impact factor: 3.377

9.  Development and Testing of Shared Decision Making Interventions for Use in Emergency Care: A Research Agenda.

Authors:  Edward R Melnick; Marc A Probst; Elizabeth Schoenfeld; Sean P Collins; Maggie Breslin; Cheryl Walsh; Nathan Kuppermann; Pat Dunn; Benjamin S Abella; Dowin Boatright; Erik P Hess
Journal:  Acad Emerg Med       Date:  2016-12       Impact factor: 3.451

10.  SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies.

Authors:  Andrew D Oxman; John N Lavis; Atle Fretheim; Simon Lewin
Journal:  Health Res Policy Syst       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.